Article

Eye disease may lead to social isolation

A recent study found that between 40% and 50% of older adults with visually impairing eye disease limit their activities due to a fear of falling, a strategy that could put them at risk for social isolation and disability.

 

Rockville, MD-A recent study found that between 40% and 50% of older adults with visually impairing eye disease limit their activities due to a fear of falling, a strategy that could put them at risk for social isolation and disability.

The study, published in Investigative Ophthalmology & Visual Science, included patients with age-related macular degeneration (AMD), glaucoma, and Fuchs’ corneal dystrophy, and a control group of older adults with good vision. Of the three groups with visual limitations, the patients with Fuchs’ corneal dystrophy were the most likely to report activity limitation due to fear of falling, followed by those with glaucoma and the AMD group.

The study, conducted at Maisonneuve-Rosemont Hospital in Montreal, also showed that people who reported activity limitation due to a fear of falling were older, were more likely to be females, had worse vision, were more likely to be depressed, and had greater comorbidity.

“It is important to know more about which activities are being limited due to fear of falling,” said Ellen E. Freeman, PhD, department of ophthalmology at the University of Montreal, Québec. “We can then develop and test interventions to help people feel more confident about their ability to safely do those activities. If we could develop a brief, effective intervention focused on select activities, I would like to see it offered in the clinical setting. Then, we could encourage people to see a low vision rehabilitation specialist if they want more training.”

The research team concluded that older adults with eye disease should stay as mobile as safely possible to help prevent morbidity associated with a sedentary lifestyle, mobility disability, and mortality.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
© 2025 MJH Life Sciences

All rights reserved.